ACERINOX ADR 1/2/EO-25 (F:ACE) — Stock Price
ACERINOX ADR 1/2/EO-25 (F:ACE) is currently trading at €6.40 EUR, down 3.03% today. Over the past 52 weeks, shares have ranged between €4.76 and €6.85. This page tracks ACERINOX ADR 1/2/EO-25's live share price on the F exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. To see how efficiently this company converts equity into cash flow, see ACE cash generation efficiency.
ACERINOX ADR 1/2/EO-25 (ACE) Stock Price Chart — Daily History & Trading Volume
The chart below tracks ACERINOX ADR 1/2/EO-25's daily closing share price and trading volume on the F exchange over the past year, giving a clear view of recent price momentum and liquidity.
ACERINOX ADR 1/2/EO-25 Income Statement — Revenue, Profit & Earnings by Year
ACERINOX ADR 1/2/EO-25's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | €5.78 Billion | €5.41 Billion | €6.61 Billion | €8.69 Billion | €6.71 Billion |
| Cost of Revenue | €3.72 Billion | €3.55 Billion | €4.43 Billion | €5.61 Billion | €4.27 Billion |
| Gross Profit | €2.06 Billion | €1.86 Billion | €2.18 Billion | €3.08 Billion | €2.43 Billion |
| Research & Development | — | — | — | — | — |
| SG&A | €33.70 Million | €29.89 Million | €28.43 Million | €23.21 Million | €176.60 Million |
| Total Operating Expenses | €5.62 Billion | €5.21 Billion | €6.05 Billion | €7.61 Billion | €5.90 Billion |
| Operating Income | €158.78 Million | €207.72 Million | €557.06 Million | €1.07 Billion | €802.15 Million |
| EBITDA | — | — | — | — | — |
| EBIT | — | — | — | — | — |
| Interest Expense | €93.43 Million | €108.11 Million | €101.04 Million | €62.80 Million | €45.28 Million |
| Income Before Tax | €89.80 Million | €341.60 Million | €355.35 Million | €831.27 Million | €765.73 Million |
| Income Tax Expense | — | — | — | — | — |
| Net Income | €-40.07 Million | €224.95 Million | €228.13 Million | €556.05 Million | €571.88 Million |
ACERINOX ADR 1/2/EO-25 Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes ACERINOX ADR 1/2/EO-25's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | €5.62 Billion | €6.47 Billion | €6.10 Billion | €6.32 Billion | €5.98 Billion |
| Total Current Assets | €3.24 Billion | €4.05 Billion | €4.32 Billion | €4.42 Billion | €3.92 Billion |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | €6.64 Million | €83.30 Million | €10.69 Million | €9.78 Million | €8.90 Million |
| Net Receivables | €471.96 Million | €546.42 Million | €555.89 Million | €570.17 Million | €767.63 Million |
| Inventory | €1.68 Billion | €2.06 Billion | €1.86 Billion | €2.16 Billion | €1.78 Billion |
| Property, Plant & Equipment | — | — | — | — | — |
| Goodwill | €164.49 Million | €181.48 Million | €51.06 Million | €51.06 Million | €51.06 Million |
| Total Liabilities | €3.52 Billion | €3.89 Billion | €3.64 Billion | €3.77 Billion | €3.77 Billion |
| Total Current Liabilities | €1.71 Billion | €1.88 Billion | €1.90 Billion | €1.95 Billion | €1.97 Billion |
| Long-term Debt | €1.32 Billion | €1.46 Billion | €1.29 Billion | €1.39 Billion | €1.37 Billion |
| Net Debt | €1.19 Billion | €1.12 Billion | €341.20 Million | €440.48 Million | €578.22 Million |
| Total Stockholder Equity | €2.06 Billion | €2.53 Billion | €2.41 Billion | €2.47 Billion | €2.16 Billion |
| Retained Earnings | €-40.07 Million | €224.95 Million | €228.13 Million | €556.05 Million | €571.88 Million |
ACERINOX ADR 1/2/EO-25 Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how ACERINOX ADR 1/2/EO-25 generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | €455.49 Million | €293.67 Million | €481.48 Million | €544.08 Million | €387.81 Million |
| Capital Expenditures | €309.80 Million | €204.78 Million | €174.90 Million | €136.72 Million | €102.14 Million |
| Free Cash Flow | €145.69 Million | €88.89 Million | €306.57 Million | €407.37 Million | €285.67 Million |
| Investing Cash Flow | — | — | — | — | — |
| Financing Cash Flow | — | — | — | — | — |
| Dividends Paid | €-154.58 Million | €154.54 Million | €149.56 Million | €129.85 Million | €135.23 Million |
| Stock-Based Compensation | — | — | — | — | — |
| Depreciation | €195.47 Million | €159.91 Million | €171.13 Million | €192.94 Million | €179.10 Million |
| Change in Cash | €-174.98 Million | €-638.82 Million | €301.21 Million | €202.55 Million | €307.69 Million |
ACERINOX ADR 1/2/EO-25 Earnings History — EPS Actual vs. Analyst Estimates
Track ACERINOX ADR 1/2/EO-25's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| May 06, 2026 | — | — | — |
| Feb 26, 2026 | — | — | — |
| Oct 31, 2025 | — | — | — |
| Jul 24, 2025 | — | — | — |
| May 08, 2025 | — | — | — |
| Nov 04, 2024 | — | — | — |